(Q30826279)

English

What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort (English)

1 reference

Europe PubMed Central

26 June 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

0 references

object named as

S Savic

7

0 references

8

object named as

M H Buch

1 reference

Europe PubMed Central

26 June 2017

author name string

K Takase

1

1 reference

Europe PubMed Central

26 June 2017

S C Horton

2

1 reference

Europe PubMed Central

26 June 2017

A Ganesha

3

1 reference

Europe PubMed Central

26 June 2017

S Das

4

1 reference

Europe PubMed Central

26 June 2017

A McHugh

5

1 reference

Europe PubMed Central

26 June 2017

language of work or name

0 references

publication date

22 May 2014

1 reference

Europe PubMed Central

26 June 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

26 June 2017

73

1 reference

Europe PubMed Central

26 June 2017

9

1 reference

Europe PubMed Central

26 June 2017

1695-1699

1 reference

Europe PubMed Central

26 June 2017

Autoimmune diseases induced by biological agents: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Biologics-induced autoimmune diseases

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Autoimmune Diseases Induced by TNF-Targeted Therapies

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Anti-TNF-induced lupus

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Vasculitis associated with tumor necrosis factor-α inhibitors

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205318

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2014-205318

1 reference

Europe PubMed Central

26 June 2017

10.1136/ANNRHEUMDIS-2014-205318

0 references

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 June 2017

ResearchGate publication ID

0 references

2-s2.0-84905179241

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30826279&oldid=1547652834"